Related Experiment Videos
Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis
Michael Pawlak1, Eginhard Schick, Martin A Bopp
1Zeptosens AG, Witterswil, Switzerland. michael.pawlak@zeptosens.com
Proteomics
|August 8, 2002
Summary
Protein microarrays offer advanced analysis for protein expression and interactions, overcoming limitations of older methods. This technology enables sensitive detection of low-abundance proteins, crucial for discovering new pharmaceutical targets.
Area of Science:
- Biotechnology
- Proteomics
- Analytical Chemistry
Background:
- Current protein analysis methods like 2-DE struggle to detect low-abundance proteins.
- Protein microarrays are poised to advance protein expression and interaction analysis.
- High-throughput applications require sensitive, efficient, and versatile protein analysis tools.
Purpose of the Study:
- To discuss key factors for developing high-performance protein microarray systems.
- To highlight the importance of detecting low-abundance proteins for biological insights.
- To demonstrate the capabilities of a novel planar waveguide-based bioanalytical system.
Main Methods:
- Utilizing proprietary planar waveguide technology for evanescent field fluorescence detection.
- Employing multiplexed, quantitative biomolecular interaction analysis in a microarray format.
- Integrating ultrasensitive fluorescence readers with microarray chips and microfluidics.
Main Results:
- The developed system achieves high read-out sensitivity for quantifying low-abundance proteins.
- Demonstrated ability to perform multiplexed, quantitative biomolecular interaction analysis.
- Generated high-fidelity data for protein expression profiling and protein-protein interaction studies.
Conclusions:
- Protein microarrays are essential for expanding the scope of protein analysis.
- The novel bioanalytical system offers significant advantages in sensitivity and throughput.
- This technology facilitates the discovery of new markers and pharmaceutical targets.